| pubmed-article:1282104 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1282104 | lifeskim:mentions | umls-concept:C0521119 | lld:lifeskim |
| pubmed-article:1282104 | lifeskim:mentions | umls-concept:C0034671 | lld:lifeskim |
| pubmed-article:1282104 | lifeskim:mentions | umls-concept:C0036751 | lld:lifeskim |
| pubmed-article:1282104 | lifeskim:mentions | umls-concept:C0085228 | lld:lifeskim |
| pubmed-article:1282104 | lifeskim:mentions | umls-concept:C0442805 | lld:lifeskim |
| pubmed-article:1282104 | lifeskim:mentions | umls-concept:C0206056 | lld:lifeskim |
| pubmed-article:1282104 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:1282104 | lifeskim:mentions | umls-concept:C1515655 | lld:lifeskim |
| pubmed-article:1282104 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:1282104 | pubmed:dateCreated | 1993-2-1 | lld:pubmed |
| pubmed-article:1282104 | pubmed:abstractText | The effects of systemic administration of fluvoxamine on extracellular serotonin (5-hydroxytryptamine, 5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) concentrations in the frontal cortex and raphe nuclei of freely moving rats were examined. Fluvoxamine significantly increased extracellular 5-HT concentrations in both regions at the two doses used (1 and 10 mg/kg i.p.). However, the increase in the raphe nuclei was several-fold that in the frontal cortex. Dialysate 5-HIAA concentrations decreased after treatment with fluvoxamine. These results confirm that 5-HT uptake inhibitors preferentially increase extracellular concentrations of 5-HT in the vicinity of cell bodies and dendrites of serotonergic neurones. | lld:pubmed |
| pubmed-article:1282104 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1282104 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1282104 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1282104 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1282104 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1282104 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1282104 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1282104 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1282104 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:1282104 | pubmed:issn | 0014-2999 | lld:pubmed |
| pubmed-article:1282104 | pubmed:author | pubmed-author:ArtigasFF | lld:pubmed |
| pubmed-article:1282104 | pubmed:author | pubmed-author:BeiAA | lld:pubmed |
| pubmed-article:1282104 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1282104 | pubmed:day | 8 | lld:pubmed |
| pubmed-article:1282104 | pubmed:volume | 229 | lld:pubmed |
| pubmed-article:1282104 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1282104 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1282104 | pubmed:pagination | 101-3 | lld:pubmed |
| pubmed-article:1282104 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:1282104 | pubmed:meshHeading | pubmed-meshheading:1282104-... | lld:pubmed |
| pubmed-article:1282104 | pubmed:meshHeading | pubmed-meshheading:1282104-... | lld:pubmed |
| pubmed-article:1282104 | pubmed:meshHeading | pubmed-meshheading:1282104-... | lld:pubmed |
| pubmed-article:1282104 | pubmed:meshHeading | pubmed-meshheading:1282104-... | lld:pubmed |
| pubmed-article:1282104 | pubmed:meshHeading | pubmed-meshheading:1282104-... | lld:pubmed |
| pubmed-article:1282104 | pubmed:meshHeading | pubmed-meshheading:1282104-... | lld:pubmed |
| pubmed-article:1282104 | pubmed:meshHeading | pubmed-meshheading:1282104-... | lld:pubmed |
| pubmed-article:1282104 | pubmed:meshHeading | pubmed-meshheading:1282104-... | lld:pubmed |
| pubmed-article:1282104 | pubmed:meshHeading | pubmed-meshheading:1282104-... | lld:pubmed |
| pubmed-article:1282104 | pubmed:meshHeading | pubmed-meshheading:1282104-... | lld:pubmed |
| pubmed-article:1282104 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1282104 | pubmed:articleTitle | Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. | lld:pubmed |
| pubmed-article:1282104 | pubmed:affiliation | Department of Neurochemistry, CSIC, Barcelona, Spain. | lld:pubmed |
| pubmed-article:1282104 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1282104 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1282104 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1282104 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1282104 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1282104 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1282104 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1282104 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1282104 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1282104 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1282104 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1282104 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1282104 | lld:pubmed |
